載入...
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)
Non-small cell lung cancer (NSCLC) has limited treatment options. Expression of the RNA-binding protein (RBP) Musashi-2 (MSI2) is elevated in a subset of non-small cell lung cancer (NSCLC) tumors upon progression, and drives NSCLC metastasis. We evaluated the mechanism of MSI2 action in NSCLC to gai...
Na minha lista:
| 發表在: | Oncogenesis |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7961039/ https://ncbi.nlm.nih.gov/pubmed/33723247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41389-021-00317-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|